Adnan Ali

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

Christopher Parker, Nicholas D. James, Chris Brawley et al. · The Lancet · 2018 · 1.3K citations · Full text

Medicine, Oncology, Urology +13

Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer

Alex Hoyle, Adnan Ali, Nicholas D. James et al. · European Urology · 2019 · 205 citations · Full text

Medicine, Oncology, Urology +12

Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer

Adnan Ali, Alex Hoyle, Áine Haran et al. · JAMA Oncology · 2021 · 137 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial

Chris Parker, Nicholas D. James, Chris Brawley et al. · PLoS Medicine · 2022 · 121 citations · Full text

Medicine, Oncology, Radiation Oncology +17

A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1

Suchira Gallage, Adnan Ali, Jose Efren Barragan Avila et al. · Cell Metabolism · 2024 · 100 citations · Full text

Medicine, Endocrinology, Pharmacology +17